These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 18358541

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Deterioration in psychosocial functioning predicts relapse/recurrence after cognitive therapy for depression.
    Vittengl JR, Clark LA, Jarrett RB.
    J Affect Disord; 2009 Jan; 112(1-3):135-43. PubMed ID: 18539337
    [Abstract] [Full Text] [Related]

  • 3. Nomothetic and idiographic symptom change trajectories in acute-phase cognitive therapy for recurrent depression.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    J Consult Clin Psychol; 2013 Aug; 81(4):615-26. PubMed ID: 23627652
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Moderators of continuation phase cognitive therapy's effects on relapse, recurrence, remission, and recovery from depression.
    Vittengl JR, Clark LA, Jarrett RB.
    Behav Res Ther; 2010 Jun; 48(6):449-58. PubMed ID: 20163785
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    J Affect Disord; 2016 Jul 15; 199():148-56. PubMed ID: 27104803
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial.
    Jarrett RB, Kraft D, Doyle J, Foster BM, Eaves GG, Silver PC.
    Arch Gen Psychiatry; 2001 Apr 15; 58(4):381-8. PubMed ID: 11296099
    [Abstract] [Full Text] [Related]

  • 9. Self-directed affiliation and autonomy across acute and continuation phase cognitive therapy for recurrent depression.
    Vittengl JR, Clark LA, Jarrett RB.
    J Pers Assess; 2004 Dec 15; 83(3):235-47. PubMed ID: 15548462
    [Abstract] [Full Text] [Related]

  • 10. Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.
    Jarrett RB, Thase ME.
    Contemp Clin Trials; 2010 Jul 15; 31(4):355-77. PubMed ID: 20451668
    [Abstract] [Full Text] [Related]

  • 11. Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    J Consult Clin Psychol; 2014 Dec 15; 82(6):1049-59. PubMed ID: 25045908
    [Abstract] [Full Text] [Related]

  • 12. Improvement in self-reported quality of life with cognitive therapy for recurrent major depressive disorder.
    Jha MK, Minhajuddin A, Thase ME, Jarrett RB.
    J Affect Disord; 2014 Dec 15; 167():37-43. PubMed ID: 25082112
    [Abstract] [Full Text] [Related]

  • 13. Improved cognitive content endures for 2 years among unstable responders to acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    Psychol Med; 2015 Nov 15; 45(15):3191-204. PubMed ID: 26098793
    [Abstract] [Full Text] [Related]

  • 14. Which depressive symptoms remain after response to cognitive therapy of depression and predict relapse and recurrence?
    Taylor DJ, Walters HM, Vittengl JR, Krebaum S, Jarrett RB.
    J Affect Disord; 2010 Jun 15; 123(1-3):181-7. PubMed ID: 19733912
    [Abstract] [Full Text] [Related]

  • 15. Quality of life after response to acute-phase cognitive therapy for recurrent depression.
    Vittengl JR, Jha MK, Minhajuddin A, Thase ME, Jarrett RB.
    J Affect Disord; 2021 Jan 01; 278():218-225. PubMed ID: 32971314
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcomes of acute treatment with cognitive therapy v. interpersonal psychotherapy for adult depression: follow-up of a randomized controlled trial.
    Lemmens LHJM, van Bronswijk SC, Peeters F, Arntz A, Hollon SD, Huibers MJH.
    Psychol Med; 2019 Feb 01; 49(3):465-473. PubMed ID: 29792234
    [Abstract] [Full Text] [Related]

  • 17. Is sleep disturbance linked to short- and long-term outcomes following treatments for recurrent depression?
    Boland EM, Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    J Affect Disord; 2020 Feb 01; 262():323-332. PubMed ID: 31735410
    [Abstract] [Full Text] [Related]

  • 18. Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol.
    Bockting CL, Kok GD, van der Kamp L, Smit F, van Valen E, Schoevers R, van Marwijk H, Cuijpers P, Riper H, Dekker J, Beck AT.
    BMC Psychiatry; 2011 Jan 14; 11():12. PubMed ID: 21235774
    [Abstract] [Full Text] [Related]

  • 19. Reducing relapse in depressed outpatients with atypical features: a pilot study.
    Jarrett RB, Kraft D, Schaffer M, Witt-Browder A, Risser R, Atkins DH, Doyle J.
    Psychother Psychosom; 2000 Jan 14; 69(5):232-9. PubMed ID: 10965287
    [Abstract] [Full Text] [Related]

  • 20. Estimating outcome probabilities from early symptom changes in cognitive therapy for recurrent depression.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    J Consult Clin Psychol; 2019 Jun 14; 87(6):510-520. PubMed ID: 31008632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.